<DOC>
	<DOCNO>NCT00090532</DOCNO>
	<brief_summary>AG-013,958 study treat patient Age-Related Macular Degeneration . A total 144 subject may enrol trial . Subjects male female least 55 year age `` wet '' age-related macular degeneration .</brief_summary>
	<brief_title>A Study Of The Safety And Efficacy Of AG-013,958 In Subjects With Subfoveal Choroidal Neovascularization Associated With Age-Related Macular Degeneration</brief_title>
	<detailed_description />
	<mesh_term>Macular Degeneration</mesh_term>
	<mesh_term>Choroidal Neovascularization</mesh_term>
	<mesh_term>Neovascularization , Pathologic</mesh_term>
	<criteria>Male and/or female subject &gt; =55 year age Subfoveal choroidal neovascularization complicate agerelated macular degeneration Subjects inform , willing able comply , investigational nature study able provide write informed consent accordance institutional regulatory guideline Other serious ocular disease condition , include diabetic retinopathy glaucoma , likely compromise visual acuity within 1 year</criteria>
	<gender>All</gender>
	<minimum_age>55 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>May 2011</verification_date>
</DOC>